Authors


Anna Seekatz, PhD

Latest:

Moving Beyond One-Size-Fits-All: The Future of Microbiome Therapy for C diff and Beyond

In Part 2, Anna Seekatz, PhD and PhD candidate Sophie Millard highlight the need for precision microbial therapies tailored to host-specific gut environments.


Albert Bach, PharmD

Latest:

What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.


Jina Saltzman, PA-C

Latest:

Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.


Jonathan Alicea

Latest:

Still Learning: Optimizing the Diagnosis and Screening of Respiratory Viruses

While the COVID-19 pandemic has helped advance respiratory diagnostics and surveillance, there are still many gaps that remain across the spectrum of healthcare.


Lauren R. Biehle, PharmD, BCPS, BCIDP

Latest:

When Should We De-Escalate Empiric Antimicrobials?

De-escalating empiric antimicrobial therapy is a strategy to combat antimicrobial resistance. Antimicrobial stewardship programs can play a major role in preserving antibiotic effectiveness and preventing unnecessary antibiotic use.


Bradley Langford, PharmD, BCIDP

Latest:

SHARE the Responsibility of Antibiotic Stewardship With Our Patients

How pharmacists can use shared decision-making to improve antibiotic use.


Erin Torrance, PharmD candidate

Latest:

Respiratory Syncytial Viral Infection: Treatment With Ziresovir in Infants

Findings from a recent phase 3 trial show promising results for the approval of ziresovir in the treatment of respiratory syncytial virus in infants.


Natalie Tucker, PharmD, BCIDP

Latest:

A Day Late and a Dollar Short: Managing Antimicrobial Drug Shortages

With antimicrobial drug shortages expected to continue globally, developing mitigation strategies is essential to prevent complications, including antimicrobial resistance.


Priya Nori, MD

Latest:

Using the NARROWS Framework to Improve Antibiotic Stewardship: A Communication Tool for Hospital Clinicians

The NARROWS framework, developed within the IDSA Core Antimicrobial Stewardship Curriculum, provides a structured, behaviorally informed approach to communication that helps stewardship teams address the social, emotional, and cultural factors influencing prescribing decisions in order to optimize antimicrobial use and combat resistance.


John Koethe, MD

Latest:

Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.


Crystal K. Hodge, PharmD, BCIDP

Latest:

The Pendulum of Progress: Soft Skills in Whole Person Clinical Training

These skills are as critical as ever, and younger clinicians and learners need them to communicate and work professionally.



Takako S. Schaninger, MD

Latest:

Challenges in the Management of Mycobacterium abscessus Complex

This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.



Frank J. Palella, MD

Latest:

Supporting Patients With HIV

Advice to community physicians regarding ways to enhance patient-provider relationships and navigate barriers that impact the management of HIV infections.


Ammara Mushtaq, MD

Latest:

Correcting the Lack of Diversity in Clinical Trials With Community-Based Studies

Ammara Mushtaq, MD, discusses the underrepresentation of different races during the pandemic, but also the newer efforts to include and represent these communities in smaller, local studies.


Megan E. Klatt, PharmD, BCIDP, DPLA

Latest:

Updates in the Treatment of Mycobacterium Tuberculosis

The latest Bench to Bedside column reviews new guidance on the treatment of drug-susceptible and drug-resistance Mycobacterium tuberculosis infections.



Philip Giordano, MD

Latest:

In These COVID 19 Times, Can We Reduce Hospitalizations Due to Skin Infections?

Shortages of health care workers and an increase in COVID-19 cases has put a severe strain on the health care system. Thus, the opportunity to reduce the hospitalizations for other conditions and expand outpatient treatment opportunities should be welcomed.


Laura Selby, DO

Latest:

Reducing Peripheral Venous Catheter Infections

Lack of data may mean bloodstream infections caused by PVCs are an overlooked cause of morbidity in hospitalized patients.


Andrew Lover, PhD, MPH, MS

Latest:

Warmer Winters Are Fueling a Surge in Tick-Borne Illnesses

Andrew Lover, PhD, MPH, discusses the shifting landscape of tick-borne illnesses during Tick-Borne Disease Awareness Month.


Karine G. Le Roch, PhD

Latest:

Kalihinol Analog Targets Apicoplast Function In Malaria Treatment

Karine G. Le Roch, PhD, discussed her research on a kalihinol analog that combats drug resistance in malaria, emphasizing the need for innovative treatments in the context of climate change and rising transmission rates.


Rebecca Fallis, MD

Latest:

Final Diagnosis: Pott Puffy Tumor With Subdural Empyema

A rare case of Pott puffy tumor occurs in an atypical patient with no risk factors, likely due to untreated sinus infection.


Athena Hobbs

Latest:

Deciphering When to Use Novel Agents in Clinical Practice

Athena Hobbs, PharmD, BCIDP, looked at this issue through the lens of treating urinary tract infections.


James F. Cummings, MD

Latest:

Evaluating Safety and Efficacy of Vaxart's Oral Vaccine's Impact on COVID-19 Variants

Part 2 with James F Cummings, MD, as he discusses the need for a stronger response to emerging variants, the importance of protecting high-risk populations, and the potential to reduce vaccine hesitancy through easier administration.


Pamela Bailey, DO, MPH

Latest:

“Triple Therapy” Facing Triple Threat

Clinicians provide an overview of intraamniotic infections and offer treatment strategies for these challenging infections.


Eli Goshorn, MD

Latest:

The Underlying Threat of Multidrug-Resistant Pathogens in the COVID-19 Era

Over half of patients admitted with positive SARS-CoV-2 testing received antibiotics, but evidence of bacterial infection is uncovered in far fewer cases. We may already be seeing the effects of antibiotic overprescribing.


Esther O. Fasanmi, PharmD, BCIDP, BCPS, AAHIVP

Latest:

Biden Administration Unveils HCV Initiative: A Significant Step Towards Public Health

The federal government is working to provide greater access to testing and treatment.


Jessica Foley, PharmD, BCIDP

Latest:

Shifting to Shorter Courses of Antibiotic Therapy for Common Pediatric Infections

In the latest SIDP column, two clinicians provide information on recent studies and guidelines directed at antibiotic durations in this patient population.


Tim Smith

Latest:

Investigational Hepatitis D Therapy Well-Tolerated, Safe for Chronic Disease at Week 48

In a study evaluating bulevirtide as monotherapy, investigators found the antiviral to be safe and tolerable following nearly a year of treatment.

© 2025 MJH Life Sciences

All rights reserved.